Rejected
Eposter Presentation
 
Accept format: PDF. The file size should not be more than 5MB
 
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
 
Submitted
Abstract
JOURNEY TO EXCELLENCE : A COMPARITIVE STUDY FROM LEARNING TO MASTERY IN RARP
Podium Abstract
Case Study
Novel Advances: Robotic Surgery
Author's Information
7
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
India
PRANANK KAKARLA pranank@yahoo.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India *
TARUN JAVALI tarunjavali@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
ABHISHEK KULKARNI drabhishekkulkarni1606@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
MANASA T manasat7@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
SANDEEP PUVVADA dr.sandeep001@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
PRASAD MYLARAPPA prasadmyluro2@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
RAMESH D arunacr1@gmail.com RAMAIAH MEDICAL COLLEGE UROLOGY BENGALURU India -
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract Content
Robot-assisted radical prostatectomy (RARP) has become the standard surgical approach for localized prostate cancer. While high-volume centers with experienced surgeons have established benchmarks for perioperative, oncological, and functional outcomes, it is crucial to evaluate whether centers in the early learning phase can achieve comparable results, especially with the support of advanced robotic platforms like the Da Vinci system. Objective :To compare the perioperative, short-term oncological, and functional outcomes of the first 100 patients undergoing RARP at our newly established robotic surgery center with data from high-volume centers reported in contemporary literature.
This retrospective study included 100 consecutive RARP cases performed by surgeons in the early phase of their robotic surgery experience. Patient demographics (age, clinical T-stage, PSA, BMI,Oncological outcomes Gleason score), perioperative parameters (operative time, docking time, console time, blood loss, transfusion rate, complication rate), and recovery metrics (catheter removal time, drain removal time, hospital stay) were analyzed. Oncological outcomes (positive surgical margin rate, biochemical recurrence) and functional outcomes (continence and erectile function rates) were compared against published data from high-volume centers.
Our center demonstrated comparable outcomes in blood loss (mean 158 mL), transfusion rate (1.9%), Oncological outcomes and complication rate (8.7%) to high-volume centers. Although operative and console times were longer, and time to continence was slightly delayed, the final continence rate at 12 months (94.6%) and positive surgical margin rate (21.7%) were within global benchmarks. Erectile dysfunction was reported in 70% of cases at 12 months, significantly higher than literature averages.
Despite being in our early phase, we achieved perioperative, oncological, and functional outcomes comparable to high-volume institutions. The robotic platform plays a critical role in standardizing outcomes, demonstrating that new centers can offer high-quality care as they progress along the learning curve.
Robot-assisted radical prostatectomy RARP Da Vinci
 
 
 
 
 
 
 
 
 
 
1835
 
Presentation Details